Showing results (491-500 of 661) with videos related to
Sort By:
Pageof 67
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase InhibitionPiyada Sitthideatphaiboon, Ana Galan-Cobo, Marcelo V Negrao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progressionLi-E Wang, Chunying Li, Sara S Strom, et al.Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2010
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancerMohammed Taoudi Benchekroun, Pierre Saintigny, Sufi M Thomas, et al.Molecular Cancer Therapeutics|October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutationsPrasanth Ganesan, Filip Janku, Aung Naing, et al.Journal of Immunotherapy and Precision Oncology|April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021Mehmet Altan, Dawen Sui, Cai Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapyBenjamin J Moeller, John S Yordy, Michelle D Williams, et al.Cancer|April 19, 2021
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiationTheresa W Guo, Faiez Saiyed, Christopher M K L Yao, et al.Cancer Cell|November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1Hongzhong Li, Yi Xiao, Qin Li, et al.The Oncologist|February 28, 2026
Phase I Trial of Binimetinib Plus Hydroxychloroquine in Patients with Previously Treated Metastatic Pancreatic CancerS Daniel Haldar, Fen Saj, So Jung Hong, et al.Seminars in Radiation Oncology|May 9, 2018
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to ActivationSteven J Frank, Pierre Blanchard, J Jack Lee, et al.Pageof 67